Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2012, Article ID 259093, 9 pages
http://dx.doi.org/10.1155/2012/259093
Research Article

Effect of Pioglitazone on the Fructose-Induced Abdominal Adipose Tissue Dysfunction

1Neuroendocrine Unit IMBICE, CICPBA, and CONICET, P.O. Box 403, 1900 La Plata, Argentina
2CENEXA, UNLP and CONICET and PAHO/WHO Collaborating Centre, 1900 La Plata, Argentina

Received 23 May 2012; Accepted 23 August 2012

Academic Editor: Hervé Schohn

Copyright © 2012 Ana Alzamendi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Popkin, “Patterns of beverage use across the lifecycle,” Physiology and Behavior, vol. 100, no. 1, pp. 4–9, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. V. S. Malik, B. M. Popkin, G. A. Bray, J. P. Després, W. C. Willett, and F. B. Hu, “Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis,” Diabetes Care, vol. 33, no. 11, pp. 2477–2483, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. L. de Koning, V. S. Malik, E. B. Rimm, W. C. Willett, and F. B. Hu, “Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men,” American Journal of Clinical Nutrition, vol. 93, no. 6, pp. 1321–1327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Kohen-Avramoglu, A. Theriault, and K. Adeli, “Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia,” Clinical Biochemistry, vol. 36, no. 6, pp. 413–420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Verma, S. Bhanot, L. Yao, and J. H. McNeill, “Vascular insulin resistance in fructose-hypertensive rats,” European Journal of Pharmacology, vol. 322, no. 2-3, pp. R1–R2, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. I. S. Hwang, H. Ho, B. B. Hoffman, and G. M. Reaven, “Fructose-induced insulin resistance and hypertension in rats,” Hypertension, vol. 10, no. 5, pp. 512–516, 1987. View at Google Scholar · View at Scopus
  7. H. Basciano, L. Federico, and K. Adeli, “Fructose, insulin resistance, and metabolic dyslipidemia,” Nutrition and Metabolism, vol. 2, article 5, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. United States Department of Health and Human Services and United States Department of Agriculture, Dietary Guidelines for Americans, United States Government Printing Office, Washington, DC, USA, 6th edition, 2005.
  9. S. Delbosc, E. Paizanis, R. Magous et al., “Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat,” Atherosclerosis, vol. 179, no. 1, pp. 43–49, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Cavarape, F. Feletto, F. Mercuri, L. Quagliaro, G. Damante, and A. Ceriello, “High-fructose diet decreases catalase mRNA levels in rat tissues,” Journal of Endocrinological Investigation, vol. 24, no. 11, pp. 838–845, 2001. View at Google Scholar · View at Scopus
  11. P. Faure, E. Rossini, J. L. Lafond, M. J. Richard, A. Favier, and S. Halimi, “Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets,” Journal of Nutrition, vol. 127, no. 1, pp. 103–107, 1997. View at Google Scholar · View at Scopus
  12. P. Faure, E. Rossini, N. Wiernsperger, M. J. Richard, A. Favier, and S. Halimi, “An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats,” Diabetes, vol. 48, no. 2, pp. 353–357, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Wei, D. Wang, F. Topczewski, and M. J. Pagliassotti, “Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance,” Journal of Nutritional Biochemistry, vol. 18, no. 1, pp. 1–9, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. O. R. Rebolledo, C. A. Marra, A. Raschia, S. Rodriguez, and J. J. Gagliardino, “Abdominal adipose tissue: early metabolic dysfunction associated to insulin resistance and oxidative stress induced by an unbalanced diet,” Hormone and Metabolic Research, vol. 40, no. 11, pp. 794–800, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Alzamendi, A. Giovambattista, A. Raschia et al., “Fructose-rich diet-induced abdominal adipose tissue endocrine dysfunction in normal male rats,” Endocrine, vol. 35, no. 2, pp. 227–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. Ashcroft, C. J. Hedeskov, and P. J. Randle, “Glucose metabolism in mouse pancreatic islets,” Biochemical Journal, vol. 118, no. 1, pp. 143–154, 1970. View at Google Scholar · View at Scopus
  17. M. H. Giroix, O. Scruel, L. Ladriere, A. Sener, B. Portha, and W. J. Malaisse, “Metabolic and secretory interactions between D-glucose and D-fructose in islets from GK rats,” Endocrinology, vol. 140, no. 12, pp. 5556–5565, 1999. View at Google Scholar · View at Scopus
  18. A. Sener and W. J. Malaisse, “Hexose metabolism in pancreatic islets. Metabolic and secretory responses to D-fructose,” Archives of Biochemistry and Biophysics, vol. 261, no. 1, pp. 16–26, 1988. View at Google Scholar · View at Scopus
  19. G. A. Kyriazis, M. M. Soundarapandian, and B. Tyrberg, “Sweet taste receptor signaling in beta cells mediates fructose-induced potentiation of glucose-stimulated insulin secretion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, pp. E524–E532, 2012. View at Google Scholar
  20. O. P. McGuinness and A. D. Cherrington, “Effects of fructose on hepatic glucose metabolism,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 6, no. 4, pp. 441–448, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Hajduch, F. Darakhshan, and H. S. Hundal, “Fructose uptake in rat adipocytes: GLUT5 expression and the effects of streptozotocin-induced diabetes,” Diabetologia, vol. 41, no. 7, pp. 821–828, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. G. J. Litherland, E. Hajduch, G. W. Gould, and H. S. Hundal, “Fructose transport and metabolism in adipose tissue of Zucker rats: diminished GLUT5 activity during obesity and insulin resistance,” Molecular and Cellular Biochemistry, vol. 261, no. 1, pp. 23–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. K. L. Stanhope, S. C. Griffen, B. R. Bair, M. M. Swarbrick, N. L. Keim, and P. J. Havel, “Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals,” American Journal of Clinical Nutrition, vol. 87, no. 5, pp. 1194–1203, 2008. View at Google Scholar · View at Scopus
  24. K. L. Stanhope and P. J. Havel, “Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup,” American Journal of Clinical Nutrition, vol. 88, no. 6, pp. 1733S–1737S, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. L. Stanhope and P. J. Havel, “Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance,” Current Opinion in Lipidology, vol. 19, no. 1, pp. 16–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Ye, P. J. Doyle, M. A. Iglesias, D. G. Watson, G. J. Cooney, and E. W. Kraegen, “Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats. Comparison with PPAR-γ activation,” Diabetes, vol. 50, no. 2, pp. 411–417, 2001. View at Google Scholar · View at Scopus
  27. M. Collino, M. Aragno, S. Castiglia et al., “Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation,” British Journal of Pharmacology, vol. 160, no. 8, pp. 1892–1902, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Minoura, S. Takeshita, J. Kimura et al., “Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor γ agonist, FK614, ameliorates insulin resistance in Zucker fatty rats,” Diabetes, Obesity and Metabolism, vol. 9, no. 3, pp. 369–378, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Alzamendi, D. Castrogiovanni, H. H. Ortega, R. C. Gaillard, A. Giovambattista, and E. Spinedi, “Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats,” Obesity, vol. 18, no. 3, pp. 441–448, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Giovambattista, A. N. Chisari, R. C. Gaillard, and E. Spinedi, “Food intake-induced leptin secretion modulates hypothalamo-pituitary-adrenal axis response and hypothalamic Ob-Rb expression to insulin administration,” Neuroendocrinology, vol. 72, no. 6, pp. 341–349, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Moreno, M. Perelló, G. Camihort et al., “Impact of transient correction of increased adrenocortical activity in hypothalamo-damaged, hyperadipose female rats,” International Journal of Obesity, vol. 30, no. 1, pp. 73–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at Google Scholar · View at Scopus
  33. W. D. McElroy and C. P. Swanson, Biostatistical Analysis, Prentice Hall-Englewood, Englewood Cliffs, NJ, USA, 1974.
  34. S. M. Grundy, B. Hansen, S. C. Smith, J. I. Cleeman, and R. A. Kahn, “Clinical management of metabolic syndrome: report of the American Heart Association/National heart, lung, and blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management,” Circulation, vol. 109, no. 4, pp. 551–556, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Miatello, M. Vázquez, N. Renna, M. Cruzado, A. P. Zumino, and N. Risler, “Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats,” American Journal of Hypertension, vol. 18, no. 6, pp. 864–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Walder, A. Filippis, S. Clark, P. Zimmet, and G. R. Collier, “Leptin inhibits insulin binding in isolated rat adipocytes,” Journal of Endocrinology, vol. 155, no. 3, pp. R5–R7, 1997. View at Google Scholar · View at Scopus
  37. B. Cohen, D. Novick, and M. Rubinstein, “Modulation of insulin activities by leptin,” Science, vol. 274, no. 5290, pp. 1185–1188, 1996. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Pérez, C. Fernández-Galaz, T. Fernández-Agulló et al., “Leptin impairs insulin signaling in rat adipocytes,” Diabetes, vol. 53, no. 2, pp. 347–353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. C. J. de Souza, M. Eckhardt, K. Gagen et al., “Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance,” Diabetes, vol. 50, no. 8, pp. 1863–1871, 2001. View at Google Scholar · View at Scopus
  40. U. Smith, S. Gogg, A. Johansson, T. Olausson, V. Rotter, and B. Svalstedt, “Thiazolidinediones (PPARγ agonists) but not PPARα agonists increase IRS-2 gene expression in 3T3-L1 and human adipocytes,” The FASEB Journal, vol. 15, no. 1, pp. 215–220, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Iwata, T. Haruta, I. Usui et al., “Pioglitazone ameliorates tumor necrosis factor-α-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-γ,” Diabetes, vol. 50, no. 5, pp. 1083–1092, 2001. View at Google Scholar · View at Scopus
  42. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. K. T. Iida, Y. Kawakami, M. Suzuki et al., “Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats,” American Journal of Physiology, vol. 284, no. 6, pp. E1125–E1130, 2003. View at Google Scholar · View at Scopus
  44. N. Houstis, E. D. Rosen, and E. S. Lander, “Reactive oxygen species have a causal role in multiple forms of insulin resistance,” Nature, vol. 440, no. 7086, pp. 944–948, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. D. Dobrian, S. D. Schriver, A. A. Khraibi, and R. L. Prewitt, “Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity,” Hypertension, vol. 43, no. 1, pp. 48–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Okuno, M. Matsuda, H. Kobayashi et al., “Adipose expression of catalase is regulated via a novel remote PPARγ-responsive region,” Biochemical and Biophysical Research Communications, vol. 366, no. 3, pp. 698–704, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Laurora, S. Pizzimenti, F. Briatore et al., “Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 3, pp. 932–942, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. B. Chopra, N. T. Georgopoulos, A. Nicholl, J. Hinley, M. B. Oleksiewicz, and J. Southgate, “Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels,” Cell Proliferation, vol. 42, no. 5, pp. 688–700, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Barbieri, C. Di Filippo, A. Esposito et al., “Effects of PPARs agonists on cardiac metabolism in littermate and cardiomyocyte-specific PPAR-γ-knockout (CM-PGKO) mice,” PLoS ONE, vol. 7, no. 4, Article ID e35999, 2012. View at Google Scholar
  50. L. Matthews, A. Berry, M. Tersigni, F. D'Acquisto, A. Ianaro, and D. Ray, “Thiazolidinediones are partial agonists for the glucocorticoid receptor,” Endocrinology, vol. 150, no. 1, pp. 75–86, 2009. View at Publisher · View at Google Scholar · View at Scopus